Al Haramain Hospital has been dedicated to the delivery of best possible health care to the people of Bangladesh in general, and to the people of the division of Sylhet in particular. This commitment is at the core of the management of this modern, 250 bed hospital equipped with the latest medical, surgical and diagnostic equipment and facilities.
With liver diseases being a major national challenge, Al Haramain Hospital has made significant investments in order to provide the best healthcare services to the community, according to the Hospital’s Chairman, Mr. Mohammed Mahtabur Rahman (Nasir) CIP.
This is in full support of the recent World Health Organization (WHO) data that revealed that over 300 million people globally are living with either Hepatitis B (HBV) or Hepatitis C (HCV), both of which are chronic viruses. Whilst in Bangladesh, recent studies estimate that 5.4% of the population is at risk of Hepatitis B (HBV) and 0.84% are vulnerable to Hepatitis C (HCV). As a result it is estimated that HBV is responsible for 60% of all cases of liver cirrhosis and 75% of chronic hepatitis.
“Viral hepatitis is now recognized as a major public health challenge that requires an urgent response,” said Dr Margaret Chan, WHO Director-General. “Vaccines and medicines to tackle hepatitis exist, and WHO is committed to helping ensure these tools reach all those who need them.”
And with the vast majority of these people having little or in some cases no access to any form of quality healthcare, Al Haramain Hospital is determined to do all it can to assist those that are at risk.